Leukocytapheresis therapy for severe ulcerative colitis

Therapeutic Apheresis

Volumn 2, Issue 2, 1998, Pages 101-104

  Sasaki, Masaya ^a   Tsujikawa, Tomonori ^a   Fujiyama, Yoshihide ^a   Bamba, Tadao ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Leukocytapheresis; Ulcerative colitis

Indexed keywords

CD8 ANTIGEN; GLUCOCORTICOID; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CYTAPHERESIS; FEMALE; HELPER CELL; HLA SYSTEM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKAPHERESIS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; REMISSION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

EID: 0031834445     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-9987.1998.tb00084.x     Document Type: Article

References (12)

1. Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1974;1:1067-70.
2. Truelove SC, Lee ECG, Willoughby CP, Kettlewell MGW. Further experience in the treatment of severe attacks of ulcerative colitis. Lancet 1978;2:1068-88.
3. Sawada K, Ohnishi K, Fukui S, Yamada K, Yamamura M, Amano K, Amano K, Wada M, Tanida N, Satomi M, Shimoyama T. Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease. J Gastroenterol 1995;30:322-9.
4. Truelove SC, Witts IJ. Cortisone in ulcerative colitis. Report on therapeutic trial. Br Med J 1953;2:375-8.
5. Oka S, Maeda K, Nishimura T, Yamawaki N. Mechanisms of leukocyte removal with fibers. Clinical application of leukocyte depletion. Proceedings of the 3rd Hokkaido Symposium on Transfusion Medicines. 1996:105-18.
6. Aoyama T, Ino Y, Ozeki M. Pharmacological studies of FUT-175, nafamostat mesilate. I. Inhibition of protease activity in vitro and vivo experiments. Jpn J Pharmacol 1984;35:203-27.
7. Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. Mediators of the inflammatory reaction. In: Jarnerot G, ed. Inflammatory bowel disease. Malmo: Corona AB and Astra, 1992.
8. Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's disease, and Clostridium difficile colitis. Gastroenterology 1988;95: 11-7.
9. Matuda T, Izumihara T, Gotanda M, Niimura T. Lymphocytapheresis using a leukocyte removal column (Cellsorba) for treatment of rheumatoid arthritis. Ther Plasmapheresis 1987; 7:73-8.
10. Emery BP, Smith GN, Panay GS. Lymphocytapheresis - A feasible treatment for rheumatoid arthritis. Br J Rheumatol 1986;25:40-3.
11. Yamamoto T, Matsuda K, Ohta S, Mizuno Y. Effect of lymphocytapheresis on steroid-resistant patients with polymyositis. Jpn J Apheresis 1996;15:112-3.
12. Lerebours E, Bussel A, Modiglini R, Bastit D, Florent C, Rabian C, Rene E, Soule J, Groupe D'Etudes Therapeutiques des Affections Inflammatories Digestives. Treatment of Crohn's disease by lymphocyte apheresis: A randomized controlled trial. Gastroenterology 1994;107:357-61.